These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 326392)
1. The pathogenesis of experimental bladder cancer. Bryan GT Cancer Res; 1977 Aug; 37(8 Pt 2):2813-6. PubMed ID: 326392 [TBL] [Abstract][Full Text] [Related]
2. A long-term study of reversible and progressive urinary bladder cancer lesions in rats fed N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide. Jacobs JB; Arai M; Cohen SM; Friedell GH Cancer Res; 1977 Aug; 37(8 Pt 2):2817-21. PubMed ID: 872108 [TBL] [Abstract][Full Text] [Related]
3. Effect of avitaminosis A and hypervitaminosis A on urinary bladder carcinogenicity of N-(4-(5-Nitro-2-furyl)-2-thiazolyl)formamide. Cohen SM; Wittenberg JF; Bryan GT Cancer Res; 1976 Jul; 36(7 PT 1):2334-9. PubMed ID: 1277139 [TBL] [Abstract][Full Text] [Related]
4. Early changes caused by N-butyl-N-(4-hydroxybutyl)nitrosamine in the bladder epithelium of different animal species. Ito N Cancer Res; 1976 Jul; 36(7 PT 2):2528-31. PubMed ID: 1277162 [No Abstract] [Full Text] [Related]
5. Metabolism and disposition of bladder carcinogens in rat and guinea pig: possible mechanism of guinea pig resistance to bladder cancer. Dawley RM; Zenser TV; Mattammal MB; Lakshmi VM; Hsu FF; Davis BB Cancer Res; 1991 Jan; 51(2):514-20. PubMed ID: 1898713 [TBL] [Abstract][Full Text] [Related]
6. Neovascularization in rats during urinary bladder carcinogenesis induced by N-[4-(5-Nitro-2-furyl)-2-thiazolyl]formamide. Cohen SM; Tatematsu M; Shinohara Y; Nakanishi K; Ito N J Natl Cancer Inst; 1980 Jul; 65(1):145-8. PubMed ID: 6930511 [TBL] [Abstract][Full Text] [Related]
7. Early lesions in experimental bladder cancer: experimental design and light microscopic findings. Cohen SM; Jacobs JB; Arai M; Johansson S; Friedell GH Cancer Res; 1976 Jul; 36(7 PT 2):2508-11. PubMed ID: 1277158 [TBL] [Abstract][Full Text] [Related]
8. The pathogenesis of bladder cancer. Friedell GH; Jacobs JB; Nagy GK; Cohen SM Am J Pathol; 1977 Nov; 89(2):431-42. PubMed ID: 920778 [TBL] [Abstract][Full Text] [Related]
9. Aspirin inhibition of N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide-induced lesions of the urinary bladder correlated with inhibition of metabolism by bladder prostaglandin endoperoxide synthetase. Cohen SM; Zenser TV; Murasaki G; Fukushima S; Mattammal MB; Rapp NS; Davis BB Cancer Res; 1981 Sep; 41(9 Pt 1):3355-9. PubMed ID: 6790163 [TBL] [Abstract][Full Text] [Related]
10. Effect of dose on urinary bladder carcinogenesis induced in F344 rats by N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide. Arai M; Cohen SM; Jacobs JB; Friedell GH J Natl Cancer Inst; 1979 Apr; 62(4):1013-6. PubMed ID: 285273 [TBL] [Abstract][Full Text] [Related]
11. Morphological effects of mitomycin C administered intravesically to normal mice and mice with N-[4-(5-nitro-2-furyl)-2-thiazolyl]-formamide-induce bladder neoplasms. Daskal Y; Soloway MS; DeFuria MD; Crooke ST Cancer Res; 1980 Feb; 40(2):261-7. PubMed ID: 7356509 [TBL] [Abstract][Full Text] [Related]
12. Effect of partial cystectomy on the induction of pre-neoplastic lesions in rat bladder initiated with N-butyl-N-(4-hydroxybutyl)nitrosamine followed by bladder carcinogens and promoters. Fukushima S; Hirose M; Okuda M; Nakanowatari J; Hatano A; Ito N Urol Res; 1982; 10(3):115-8. PubMed ID: 7135697 [TBL] [Abstract][Full Text] [Related]
13. Effect of sodium phenobarbital and sodium saccharin in AIN-76A diet on carcinogenesis initiated with N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide and N,N-dibutylnitrosamine in male F344 rats. Imaida K; Wang CY Cancer Res; 1986 Dec; 46(12 Pt 1):6160-4. PubMed ID: 3779637 [TBL] [Abstract][Full Text] [Related]
14. Promoting effect of saccharin and DL-tryptophan in urinary bladder carcinogenesis. Cohen SM; Arai M; Jacobs JB; Friedell GH Cancer Res; 1979 Apr; 39(4):1207-17. PubMed ID: 421204 [TBL] [Abstract][Full Text] [Related]
15. Enhancing effect of allopurinol on the induction of bladder cancer in rats by n-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide. Wang CY; Hayashida S; Pamukcu AM; Bryan GT Cancer Res; 1976 May; 36(5):1551-5. PubMed ID: 1268818 [TBL] [Abstract][Full Text] [Related]
16. Synergistic effect of urinary bladder carcinogenesis in rats treated with N-butyl-n-(4-hydroxybutyl)nitrosamine, N-(4-(5-nitro-2-furyl)-2-thiazolyl)formamide,N-2-fluorenylacetamide, and 3,3'-dichlorobenzidine. Tsuda H; Miyata Y; Murasaki G; Kinoshita H; Fukushima S Gan; 1977 Apr; 68(2):183-92. PubMed ID: 892292 [No Abstract] [Full Text] [Related]
17. Early lesions in experimental bladder cancer: scanning electron microscopy of cell surface markers. Jacobs JB; Arai M; Cohen SM; Friedell GH Cancer Res; 1976 Jul; 36(7 PT 2):2512-7. PubMed ID: 1277159 [TBL] [Abstract][Full Text] [Related]
18. Low susceptibility of analbuminemic rats to induction of bladder cancer by N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide. Hosaka Y; Muramatsu M; Matsushima T; Niijima T; Nagase S Jpn J Cancer Res; 1985 Jul; 76(7):577-82. PubMed ID: 3928553 [TBL] [Abstract][Full Text] [Related]
19. Inhibition by aspirin of N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide initiation and sodium saccharin promotion of urinary bladder carcinogenesis in male F344 rats. Sakata T; Hasegawa R; Johansson SL; Zenser TV; Cohen SM Cancer Res; 1986 Aug; 46(8):3903-6. PubMed ID: 3731063 [TBL] [Abstract][Full Text] [Related]
20. Biotransformation of the bladder carcinogen N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide in mice. Swaminathan S; Bryan GT Cancer Res; 1984 Jun; 44(6):2331-8. PubMed ID: 6722771 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]